Fairvalue-Calculator Fairvalue-Calculator
EN DE

TCI GENE Inc (6879) Fair Value & Analysis

Healthcare · TW · Market cap 979M TWD

Price37.00 TWD
Fair Value25.85 TWD
Upside-30.1%
Quality92/100
Evidence: High Range 20.92 TWD – 32.32 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

TCI GENE Inc (6879) currently trades at 37.00 TWD, while our model-based Fair Value estimate is 25.85 TWD — implying the stock looks roughly 30.1% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

TCI GENE Inc., together with its subsidiaries, provides genetic testing and assessment services in Taiwan and Mainland China. It operates through Inspection and Consumable Products segments. The company offers memory, anti-aging, health management, child growth and development, nutritional metabolism and absorption, OB weight management, and SC skin management genetic testing; gut microbiota testing; and LDT cardiovascular drug gene testing services. It also provides precision prediction and personalized health management plans; and adipose-derived mesenchymal stem cells, natural killer immune cells, and immune cell storage programs. In addition, the company manufactures and sells testing reagents, health food, and beauty products; and health and nutritional supplements. TCI GENE Inc. was founded in 2011 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is TCI GENE Inc (6879) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 25.85 TWD versus a price of 37.00 TWD — about −30% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6879?
Our 21-model fair value for TCI GENE Inc is 25.85 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 37.00 TWD.
What is the quality score of 6879?
TCI GENE Inc has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.